Literature DB >> 12356820

Relaxation of beta-structure in tear lipocalin and enhancement of retinoid binding.

Oktay K Gasymov1, Adil R Abduragimov, Taleh N Yusifov, Ben J Glasgow.   

Abstract

PURPOSE: To study binding of retinoids to human tear lipocalin (TL) to assess factors influencing ligand affinity and delivery. Mechanistic features of retinoid interactions with TL were investigated, including the influence of the retinoid functional group on ligand affinity, the relative affinity of retinol versus fatty acids, the influence of relaxation of secondary structure in TL on ligand binding, the role of specific conserved hydrophobic residues in maintaining the rigidity of the secondary structure, and the potential release of retinol in a low-pH environment that promotes structural relaxation at lipid interfaces.
METHODS: The binding and displacement of retinoids were monitored by quenching of protein fluorescence. Circular dichroic spectra were used to evaluate structural and conformational changes in TL-retinoid complexes. Site-directed mutagenesis was performed to determine the influence of the residues Trp17, Ile98, Gly15, and Leu19 in retinoid binding to TL and to correlate these effects with changes in secondary structure.
RESULTS: Retinal and retinol bound TL with similar affinity. Fatty acids competed with retinoids for the same binding site on TL. Optical activity associated with retinal binding to TL was reduced in the presence of palmitic acid. In comparison with TL, the mutants W17C and I98C displayed relaxation of secondary structure, manifested as diminution of beta-sheet content in conjunction with a destabilization in urea, reduced aromatic asymmetry, and greater binding affinity for retinoids. Unlike fatty acids, retinol is not released from TL at low pH.
CONCLUSIONS: The unique spectral properties of retinoids permit the simultaneous study of structural changes in TL and ligand binding. Retinoid binding is enhanced by specific mutations that induce relaxation of TL structure but is altered minimally by the functional group in retinoids. Two key hydrophobic residues, Trp17 (A strand) and Ile98 (G strand), contribute to backbone rigidity and influence retinoid binding through their participation in an internal hydrophobic cluster and external hydrophobic patch, respectively. The contributions of these sites to ligand binding may explain their conserved nature in the lipocalin family. Information regarding the binding and release of retinoids compared with fatty acids favors a role for TL in the delivery of lipids other than retinol to the tear film interfaces.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356820

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

2.  The conserved disulfide bond of human tear lipocalin modulates conformation and lipid binding in a ligand selective manner.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biochim Biophys Acta       Date:  2011-04-03

3.  Interaction of ceramides and tear lipocalin.

Authors:  Ben J Glasgow; Adil R Abduragimov
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-11       Impact factor: 4.698

4.  Restoration of structural stability and ligand binding after removal of the conserved disulfide bond in tear lipocalin.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biochem Biophys Res Commun       Date:  2014-09-16       Impact factor: 3.575

Review 5.  Synthesis and use of stable isotope enriched retinals in the field of vitamin A.

Authors:  Prativa B S Dawadi; Johan Lugtenburg
Journal:  Molecules       Date:  2010-03-15       Impact factor: 4.411

6.  Tear Lipocalin and Lipocalin-Interacting Membrane Receptor.

Authors:  Ben J Glasgow
Journal:  Front Physiol       Date:  2021-08-19       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.